Modalert 100mg Research Overview
Modalert 100mg is a pharmaceutical-grade modafinil compound manufactured by Sun Pharmaceuticals Industries, developed for advanced laboratory research into wakefulness promotion mechanisms. This eugeroic agent represents a key tool for investigating cognitive enhancement pathways, dopaminergic system modulation, and circadian rhythm research protocols. Researchers examining neurochemical pathways can evaluate modafinil’s unique mechanism as a selective dopamine reuptake inhibitor with histaminergic and orexinergic activity. Each tablet delivers precisely 100mg modafinil in pharmaceutical tablet form, manufactured under GMP standards for consistent research outcomes. Scientists studying cognitive function, alertness mechanisms, and neurotransmitter systems frequently investigate this compound alongside other research chemicals from Stroid UK Shop for comprehensive neurochemical studies.
Laboratory Research Applications
Modafinil research encompasses multiple neurological and cognitive pathways studied in laboratory settings. Researchers investigate its effects on dopamine transporter binding, examining how selective DAT inhibition influences synaptic dopamine concentrations without traditional stimulant-like mechanisms. Scientists studying sleep-wake cycles analyse modafinil’s interaction with orexin neurons and histaminergic pathways in the hypothalamus. Cognitive research applications include examining working memory enhancement, attention span modulation, and executive function improvements in controlled laboratory environments. Neuroplasticity studies investigate modafinil’s potential effects on AMPA receptor trafficking and long-term potentiation mechanisms. Researchers exploring brain and memory support compounds often combine modafinil studies with other nootropic agents to understand synergistic cognitive enhancement pathways. Additional research areas include circadian biology, neuropharmacology, and behavioural studies examining motivation and reward systems.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Modafinil |
| Strength | 100mg per tablet |
| Manufacturer | Sun Pharmaceuticals Industries |
| CAS Number | 68693-11-8 |
| Molecular Formula | C₁₅H₁₅NO₂S |
| Molecular Weight | 273.35 g/mol |
| Form | Oral tablets |
| Storage | Room temperature, dry conditions |
Research laboratories studying cognitive enhancement frequently source modafinil alongside selective androgen receptor modulators and research peptides for comprehensive neurochemical investigations. Sun Pharmaceuticals maintains rigorous quality control standards, ensuring consistent potency and purity for reliable research outcomes across multiple experimental protocols.
Research Compliance Statement
Modalert 100mg is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, clinical use, or therapeutic applications. Researchers must possess appropriate laboratory credentials and follow institutional guidelines for handling pharmaceutical research compounds. This product is designed for qualified researchers investigating modafinil’s neurochemical properties, cognitive enhancement mechanisms, and neuropharmacological pathways in controlled laboratory environments. All studies should comply with relevant research ethics guidelines and institutional review board requirements when conducting modafinil research protocols.
